Cardiology
Commentary
Aspirin for primary prevention: It depends
No wonder our patients are confused!
PURLs
Should you switch the DAPT agent one month after ACS?
A randomized controlled trial says “Yes,” but current guidelines say “No.”
Applied Evidence
Aspirin for primary prevention: USPSTF recommendations for CVD and colorectal cancer
Patient age, baseline cardiovascular disease risk, bleeding risk, and personal preference regarding aspirin use are key to decision making. A...
Conference Coverage
Studies link TMAO to microbiome, reveal new heart disease target
MIAMI – TMAO alters cholesterol and bile acid metabolism, upregulates inflammatory pathways, and promotes foam cell formation, all of which worsen...
From the Journals
Renal denervation reduced BP in sham-controlled trials, meta-analysis shows
Identifying the patients who responded extremely well to the therapy should be a research priority.
News from the FDA/CDC
FDA approves multiple ambrisentan generics for patients with PAH
The FDA also approved two shared system REMS programs for ambrisentan. The first, Ambrisentan REMS, comprises the brand sponsor and three...
From the Journals
More chest compression–only CPR leads to increased survival rates
This alternative for bystanders raises both CPR performance rates and patient survival.
Practice Alert Podcast
The 2018 AHA/ACC cholesterol guidelines: What’s changed?
Treating to a target cholesterol level is back for many, and there is a role for medications other than just statins in certain patients...
News
Some cardiac devices vulnerable to cybersecurity threats
Video
BP control slowed brain damage in elderly hypertensives
NEW ORLEANS – Elderly hypertensive patients treated to a systolic blood pressure of 130 mm Hg had less white matter disease progression than...
Conference Coverage
Abstinence by moderate drinkers improves their AFib
NEW ORLEANS – AFib recurrence risk was cut in half by alcohol abstinence.